Cargando…
Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511056/ https://www.ncbi.nlm.nih.gov/pubmed/35856503 http://dx.doi.org/10.1111/jvim.16495 |
| _version_ | 1784797578474291200 |
|---|---|
| author | Rishniw, Mark White, Maurice |
| author_facet | Rishniw, Mark White, Maurice |
| author_sort | Rishniw, Mark |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9511056 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95110562022-09-30 Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” Rishniw, Mark White, Maurice J Vet Intern Med Letters to the Editor John Wiley & Sons, Inc. 2022-07-20 2022 /pmc/articles/PMC9511056/ /pubmed/35856503 http://dx.doi.org/10.1111/jvim.16495 Text en © 2022 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC. on behalf of the American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Rishniw, Mark White, Maurice Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title | Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title_full | Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title_fullStr | Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title_full_unstemmed | Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title_short | Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study” |
| title_sort | letter regarding “alvac‐fil2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: a pilot study” |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511056/ https://www.ncbi.nlm.nih.gov/pubmed/35856503 http://dx.doi.org/10.1111/jvim.16495 |
| work_keys_str_mv | AT rishniwmark letterregardingalvacfil2afelineinterleukin2immunomodulatorasatreatmentforsarcoidsinhorsesapilotstudy AT whitemaurice letterregardingalvacfil2afelineinterleukin2immunomodulatorasatreatmentforsarcoidsinhorsesapilotstudy |